Menu

Star on GitHub · 3.2k

CVE-2025-62575

8.3 · HIGH

NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database.

Published Dec 2, 2025CWE-732EPSS 0.42%

Overview

CVE-2025-62575 is a high-severity vulnerability. It was published on December 2, 2025 and has a CVSS 3.1 base score of 8.3 (HIGH).

This vulnerability has a CVSS 3.1 base score of 8.3, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

Technical description

NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2025-62575?

CVE-2025-62575 is a high-severity vulnerability. It was published on December 2, 2025 and has a CVSS 3.1 base score of 8.3 (HIGH).

How severe is CVE-2025-62575?

This vulnerability has a CVSS 3.1 base score of 8.3, rated HIGH. It can be exploited remotely over the network. Some level of privileges is required for exploitation.

How do I fix or remediate CVE-2025-62575?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2025-62575?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2025-62575 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related HIGH CVEs from 2025

View all